- Conditions
- Microbiota, Gut Microbiome, Eczema, Microbiome
- Interventions
- Tailored Recommendations, Consult Call, Educational Email Series
- Dietary Supplement · Behavioral
- Lead sponsor
- Seeding Inc
- Industry
- Eligibility
- 0 Months to 3 Months
- Enrollment
- 250 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Austin, Texas
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 24
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Dermatitis, Atopic, Pruritus, Dermatitis Eczema
- Interventions
- ASN008 TG, Placebo TG
- Drug
- Lead sponsor
- Asana BioSciences
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 4
- States / cities
- Cortland, New York • High Point, North Carolina • San Antonio, Texas + 1 more
- Conditions
- Atopic Dermatitis
- Interventions
- FB825 or Placebo in subcutaneous route, FB825 in intravenous route
- Drug
- Lead sponsor
- Oneness Biotech Co., Ltd.
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 22 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Anaheim, California
- Conditions
- Eczema
- Interventions
- topical colloidal oatmeal formulation with a modified plant oil, topical colloidal oatmeal formulation
- Other
- Lead sponsor
- GlycosBio, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Atopic Dermatitis
- Interventions
- Pimecrolimus, Placebo
- Drug
- Lead sponsor
- Novartis
- Industry
- Eligibility
- 20 Years and older · Male only
- Enrollment
- 70 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2004 – 2005
- U.S. locations
- 3
- States / cities
- New York, New York • Norfolk, Virginia
- Conditions
- Atopic Dermatitis
- Interventions
- ADX-914, Placebo
- Drug
- Lead sponsor
- Q32 Bio Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 102 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 24
- States / cities
- Birmingham, Alabama • Fountain Valley, California • Los Angeles, California + 20 more
- Conditions
- Tinea Cruris
- Interventions
- 33525, Placebo
- Drug
- Lead sponsor
- Medicis Global Service Corporation
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 483 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 17
- States / cities
- Fremont, California • Los Angeles, California • Miami, Florida + 14 more
- Conditions
- Atopic Dermatitis
- Interventions
- Not listed
- Lead sponsor
- LEO Pharma
- Industry
- Eligibility
- Up to 16 Years
- Enrollment
- 8,071 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2019
- U.S. locations
- 198
- States / cities
- Alabaster, Alabama • Anniston, Alabama • Birmingham, Alabama + 155 more
- Conditions
- Atopic Dermatitis, Psoriasis
- Interventions
- Phone calls, Desoximetasone 0.25% spray
- Behavioral · Drug
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017
- U.S. locations
- 1
- States / cities
- Winston-Salem, North Carolina
- Conditions
- Atopic Dermatitis
- Interventions
- Crisaborole ointment 2%
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 3 Months to 23 Months
- Enrollment
- 137 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 23
- States / cities
- Hot Springs, Arkansas • San Diego, California • San Francisco, California + 17 more
- Conditions
- Atopic Dermatitis
- Interventions
- S-777469 400 mg, S-777469 800 mg, Placebo
- Drug
- Lead sponsor
- Shionogi
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 209 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 33
- States / cities
- Hot Springs, Arkansas • Los Angeles, California • Oceanside, California + 28 more
- Conditions
- Dermatitis, Atopic
- Interventions
- Mepolizumab 100 mg, Placebo matching mepolizumab
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 34 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017
- U.S. locations
- 11
- States / cities
- Fort Smith, Arkansas • Fremont, California • Santa Ana, California + 8 more
- Conditions
- Atopic Dermatitis
- Interventions
- DSXS topical
- Drug
- Lead sponsor
- Sun Pharmaceutical Industries, Inc.
- Industry
- Eligibility
- 6 Months to 17 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2017
- U.S. locations
- 1
- States / cities
- Hawthorne, New York
- Conditions
- Atopic Dermatitis, Psoriasis
- Interventions
- Not listed
- Lead sponsor
- National Jewish Health
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2023
- U.S. locations
- 1
- States / cities
- Denver, Colorado
- Conditions
- Microbiota, Eczema, Microbiome, Gut Microbiome
- Interventions
- Tailored Recommendations, Consult Call, Email Series
- Dietary Supplement · Behavioral
- Lead sponsor
- Seeding Inc
- Industry
- Eligibility
- 0 Months to 3 Months
- Enrollment
- 100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Fredericksburg, Texas
- Conditions
- Smoking, Acne, Atopic Dermatitis, Aging
- Interventions
- Skin Surface Lipid Collection and Skin Barrier Function
- Other
- Lead sponsor
- University of California, Davis
- Other
- Eligibility
- 12 Years and older
- Enrollment
- 41 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Sacramento, California
- Conditions
- Atopic Dermatitis
- Interventions
- Combination of pimecrolimus and fluticasone, pimecrolimus
- Drug
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 2 Years to 65 Years
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2005
- U.S. locations
- 3
- States / cities
- Denver, Colorado • Chicago, Illinois • Houston, Texas
- Conditions
- Atopic Dermatitis, Eczema
- Interventions
- Lebrikizumab, Placebo, Topical Corticosteroid (TCS)
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 6 Months to 17 Years
- Enrollment
- 367 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 21
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • North Little Rock, Arkansas + 18 more
- Conditions
- Atopic Dermatitis
- Interventions
- Pimecrolimus, Topical corticosteroids
- Drug
- Lead sponsor
- MEDA Pharma GmbH & Co. KG
- Industry
- Eligibility
- 3 Months to 12 Months
- Enrollment
- 2,418 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2010
- U.S. locations
- 30
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 25 more
- Conditions
- Pruritus, Prurigo Nodularis, Atopic Dermatitis, Psoriasis
- Interventions
- 5 mg Serlopitant Tablets
- Drug
- Lead sponsor
- Vyne Therapeutics Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 558 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 46
- States / cities
- Birmingham, Alabama • Fremont, California • North Hollywood, California + 42 more
- Conditions
- Dermatitis, Atopic
- Interventions
- PF-04965842 100 mg, PF-04965842 200 mg, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 387 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 29
- States / cities
- Birmingham, Alabama • Encinitas, California • San Diego, California + 21 more
- Conditions
- Atopic Dermatitis
- Interventions
- KT-621, Placebo
- Drug · Other
- Lead sponsor
- Kymera Therapeutics, Inc.
- Industry
- Eligibility
- 12 Years to 75 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 20
- States / cities
- Birmingham, Alabama • North Little Rock, Arkansas • Freemont, California + 14 more
- Conditions
- Dermatitis, Dermatitis, Atopic, Eczema, Non-atopic Healthy Controls
- Interventions
- Not listed
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 150 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2015
- U.S. locations
- 3
- States / cities
- Denver, Colorado • Rochester, New York • Portland, Oregon
- Conditions
- Dermatitis, Atopic
- Interventions
- BI 655130, Placebo
- Drug
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 51 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 10
- States / cities
- Scottsdale, Arizona • Fort Myers, Florida • Miami, Florida + 6 more